Reduced stroke, embolism, bleeding risk with apixaban in nonvalvular AF
07 Apr 2020
byRoshini Claire Anthony
Among patients with nonvalvular atrial fibrillation (AF), treatment with apixaban was associated with a lower rate of ischaemic stroke, systemic embolism, and major bleeding compared with rivaroxaban, according to a large study assessing patients in routine care.
Reduced stroke, embolism, bleeding risk with apixaban in nonvalvular AF
07 Apr 2020